Skip to main content
OpenTrials

Clinical trial condition

Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma

Explore clinical trials studying Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma trial results

Completed

Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

NCT01979536

Conditions
Anaplastic Large Cell Lymphoma, ALK-Positive, Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma, Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma, +12 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 154 locations
View Trial Details

Related conditions